Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Kinase Domain ◽

Durable Response ◽

Domain Duplication ◽

Osimertinib is an effective epidermal growth factor receptor-tyrosine kinase inhibitor choice for lung cancer with epidermal growth factor receptor exon 18–25 kinase domain duplication

Anti-Cancer Drugs ◽

10.1097/cad.0000000000001148 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Long-Dan Zhang ◽

Han Gao ◽

Shou-Ming Qin ◽

Qian Zeng ◽

Quan-Fang Chen

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Kinase Domain ◽

Domain Duplication ◽

P1.01-36 Thoracic Surgery in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.592 ◽

2018 ◽

Vol 13 (10) ◽

pp. S474

Author(s):

C. Hsiao ◽

S. Kuo ◽

K. Chen ◽

J. Chen

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy

Annals of Translational Medicine ◽

10.21037/atm.2018.10.06 ◽

2018 ◽

Vol 6 (20) ◽

pp. 407-407 ◽

Cited By ~ 3

Author(s):

Ye Ning ◽

Minwei Bao ◽

Xiaoxia Yan ◽

Dong Xie ◽

Gening Jiang

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal growth factor receptor (EGFR) and phosphoinositide-3-kinase catalytic alpha (PIK3CA) mutations in non-small cell lung cancer (NSCLC) and response to tyrosine kinase inhibitor therapy

10.5353/th_b4663242 ◽

2011 ◽

Author(s):

Kit-chi Choy

Keyword(s):

Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Pik3ca Mutations ◽

Epidermal Growth ◽

Phosphoinositide 3 Kinase

Biological Markers for Non–Small Cell Lung Cancer Patient Selection for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-0261 ◽

2006 ◽

Vol 12 (12) ◽

pp. 3652-3656 ◽

Cited By ~ 52

Author(s):

Paul A. Bunn ◽

Rafal Dziadziuszko ◽

Marileila Varella-Garcia ◽

Wilbur A. Franklin ◽

Samir E. Witta ◽

...

Keyword(s):

Lung Cancer ◽

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Epidermal Growth ◽

Selection For

PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy

Bioorganic & Medicinal Chemistry ◽

10.1016/j.bmc.2018.02.007 ◽

2018 ◽

Vol 26 (8) ◽

pp. 1609-1613 ◽

Cited By ~ 3

Author(s):

Akira Makino ◽

Anna Miyazaki ◽

Ayaka Tomoike ◽

Hiroyuki Kimura ◽

Kenji Arimitsu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Osimertinib Administration as the Primary Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy for Brain Metastasis of De Novo T790M-positive Lung Cancer

Internal Medicine ◽

10.2169/internalmedicine.3169-19 ◽

2019 ◽

Vol 58 (20) ◽

pp. 3029-3031 ◽

Cited By ~ 1

Author(s):

Susumu Noguchi ◽

Hiroaki Kawachi ◽

Akari Fukao ◽

Satoshi Terashita ◽

Tomoko Tajiri ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Brain Metastasis ◽

Kinase Inhibitor ◽

De Novo ◽

Growth Factor Receptor ◽

Timing of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Patients With Lung Cancer WithEGFRMutations

Journal of Clinical Oncology ◽

10.1200/jco.2012.43.1858 ◽

2012 ◽

Vol 30 (27) ◽

pp. 3330-3336 ◽

Cited By ~ 33

Author(s):

Teresa Moran ◽

Lecia V. Sequist

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181f0bee0 ◽

2010 ◽

Vol 5 (11) ◽

pp. 1855-1858 ◽

Cited By ~ 31

Author(s):

Joel W. Neal ◽

Rebecca S. Heist ◽

Panos Fidias ◽

Jennifer S. Temel ◽

Mark Huberman ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Effective tyrosine kinase inhibitor re-treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer patient: a case report

Precision Cancer Medicine ◽

10.21037/pcm-20-56 ◽

2020 ◽

Vol 3 ◽

pp. 29-29

Author(s):

Alessandro Galletti ◽

Marco Russano ◽

Fabrizio Citarella ◽

Bruno Vincenzi ◽

Giuseppe Tonini ◽

...

Keyword(s):

Lung Cancer ◽

Case Report ◽

Growth Factor ◽

Lung Cancer Patient ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽